NewsRx

Search our medical news database

Advanced Neuromodulation Systems

U.S. FDA grants IDE approval to investigate device for essential tremor

Published in Health Insurance Week, May 1st, 2005

Advanced Neuromodulation Systems (ANS) has received a U.S. Food & Drug Administration (FDA) Investigational Device Exemption (IDE) approval to implant 160 patients at 12 sites to investigate the safety and efficacy of the ANS Libra Deep Brain Stimulation (DBS) System to treat essential tremor.

The company has identified a number of sites for the clinical study. The first implants of the Libra IPG System are anticipated to occur in the second quarter of this year.

The company also announced the submission to the FDA of an amendment to its IDE application to investigate the ANS Libra DBS System to treat Parkinson disease. ANS anticipates receiving this...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook